You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》花旗下調醫渡科技(02158.HK)目標價至35元 評級「買入」
花旗發表報告,指醫渡科技(02158.HK)2022財年收入錄12億元人民幣,按年增43%,淨虧損擴至7.62億元人民幣,符合該行預測,管理層表示由於人手和營銷費用增加以致虧損。 該行引述管理層指,由於營運效率提高,指引2023財年收入將快速增長,淨虧損有望大幅收窄,並在2024財年達收支平衡。 該行表示,將公司在2023及2024財年收入預測分別下調7%及10%,以反映最新業務走勢及新冠疫情影響,並料2023及2024財年分別錄虧損4.03億及3,800萬元人民幣,2025財年料扭虧轉賺2.88億元人民幣,並將其目標價由45元下調至35元,維持「買入」評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account